CLINICAL RESEARCH CURRICULUM AND MENTORSHIP PROGRAM

(摘自申请者的摘要)德克萨斯大学休斯顿分校 医学院和公共卫生学院与大学合作 德州医学安德森癌症中心提出一项联合计划，以开发 成功的临床研究人员。该程序具有以下功能： 与其附属的3个主要机构密切合作 大学系统，位于美国最大的医疗中心-a 年轻的医学院与逐步增加的助学金，一个强大的 公共卫生学院(在NIH获奖学校中排名第三)，以及 大型癌症中心(NCI获奖总数第二名)。 高度敬业、成就斐然、多元化的教职员工和顾问委员会。这个 Pi是一位新生儿和流行病学家，米歇尔·贝恩是杰出的 德克萨斯大学休斯顿分校医学和公共卫生教授；合作者是一位杰出的 肿瘤学家和Ruth Harriet Ainsworth发展学教授 治疗学，医学教授，实验室医学教授和 安德森医学中心的病理学。咨询委员会成员包括该学院院长。 公共卫生学院；负责教育项目的副校长和 研究管理部和MD Anderson的内外科主任； 以及内科、儿科、产科和综合医学的主任委员 生物学(1998年诺贝尔医学奖获得者)，医学院。 该计划包括1)由Success教授的综合课程 来自所有3个机构的教师和2)在 每个参与者都与一名计划导师和一名临床导师一起工作 准备一份值得资助的研究计划。成功的参与者 完成课程将获得认证，并提供进一步的学费 公共卫生学院的课程。 庞大的患者群体和临床研究的资源基础。最后的 去年，德克萨斯大学休斯顿分校有100多万人次门诊，23.3万家医院 招生人数和1.08亿美元的研究支出；M.D.安德森 近2万名新癌症患者，并有超过1.2亿美元的研究资金 支出。 在参与者方面，申请者预计将保持大约 每年有25人参加导师计划，平均至少有 每期课程有80人参加。 这一计划很可能在开发高效的临床应用方面具有成本效益。 在寻求研究支持和研究方面具有竞争力的研究人员 了解与健全的临床相关的复杂问题 研究。“

(Adapted from the applicant's abstract) The University of Texas-Houston Medical School and School of Public Health in conjunction with the University of Texas M.D. Anderson Cancer Center propose a joint program to develop successful clinical investigators. This program has the following features: Close collaboration between 3 major institutions affiliated with the same university system and located in the largest medical center in the U.S.-a young medical school with progressively increasing grant awards, a strong School of Public Health (3rd among such schools in total NIH awards), and a large cancer center (2nd in total NCI awards). Highly committed, accomplished, and diverse faculty and Advisory Board. The PI is a neonatologist and epidemiologist and the Michelle Bain Distinguished Professor of Medicine and Public Health at UT Houston; the Co-PI is an eminent oncologist and the Ruth Harriet Ainsworth Professor of Developmental Therapeutics, Professor of Medicine, and Professor of Laboratory Medicine and Pathology at M.D. Anderson. The Advisory Board includes the Dean of the School of Public Health; the Vice Presidents of Educational Programs and of Research Administration and the Heads of Medicine and Surgery at MD Anderson; and the Chairmen of Internal Medicine, Pediatrics, Obstetrics, and Integrative Biology (1998 Nobel Prize Winner in Medicine) at the Medical School. A program that includes 1) a comprehensive curriculum taught by successful faculty from all 3 institutions and 2) an intensive mentorship program in which participants each work with a program mentor and a clinical mentor to prepare a research proposal worthy of funding. Participants who successfully complete the program will be certified and provided tuition for further courses at the School of Public Health. A large patient population and resource base for clinical research. Last year, UT Houston had more than 1 million outpatient visits, 233,000 hospital admissions and $108 million in research expenditures; M.D. Anderson enrolled almost 20,000 new cancer patients and had more than $120 million in research expenditures. In terms of participants, the applicants anticipate maintaining approximately 25 participants in the mentorship program each year and an average of at least 80 participants at each session of the curriculum. This program is likely to be cost-effective in developing productive clinical investigators "who are competitive in seeking research support and knowledgeable about the complex issues associated with sound clinical research."